Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (71-80 of 428) with videos related to

Pageof 43
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 8, 2026
Small airway abnormalities in asthmatic patients with persistent airflow limitationMarco Contoli, Federico Baraldi, Luca Morandi, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 5, 2008
New drugs targeting Th2 lymphocytes in asthmaGaetano Caramori, David Groneberg, Kazuhiro Ito, et al.
The International Journal of Biochemistry & Cell Biology|October 19, 2010
Mechanisms involved in lung cancer development in COPDGaetano Caramori, Paolo Casolari, Giorgio Narciso Cavallesco, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2008
Pathophysiology of viral-induced exacerbations of COPDAlfredo Potena, Gaetano Caramori, Paolo Casolari, et al.
Current Opinion in Pharmacology|May 4, 2007
Models of infection and exacerbations in COPDAlberto Papi, Marco Contoli, Gaetano Caramori, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 18, 2020
Treatment strategies for asthma: reshaping the concept of asthma managementAlberto Papi, Francesco Blasi, Giorgio Walter Canonica, et al.
Clinical Drug Investigation|February 23, 2012
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthmaSimone Gerzeli, Carla Rognoni, Silvana Quaglini, et al.
Asthma Research and Practice|January 30, 2021
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategyÁlvaro A Cruz, Sara Barile, Elena Nudo, et al.
BMC Pulmonary Medicine|March 19, 2016
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthmaJ Christian Virchow, Roberto Rodriguez-Roisin, Alberto Papi, et al.
Allergy|October 6, 2021
The ICQ asthma algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma managementAlberto Papi, Milos Jesenak, Franco Alfano, et al.
Pageof 43

Showing results (71-80 of 428) with videos related to

Sort By:
Pageof 43
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 8, 2026
Small airway abnormalities in asthmatic patients with persistent airflow limitationMarco Contoli, Federico Baraldi, Luca Morandi, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 5, 2008
New drugs targeting Th2 lymphocytes in asthmaGaetano Caramori, David Groneberg, Kazuhiro Ito, et al.
The International Journal of Biochemistry & Cell Biology|October 19, 2010
Mechanisms involved in lung cancer development in COPDGaetano Caramori, Paolo Casolari, Giorgio Narciso Cavallesco, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2008
Pathophysiology of viral-induced exacerbations of COPDAlfredo Potena, Gaetano Caramori, Paolo Casolari, et al.
Current Opinion in Pharmacology|May 4, 2007
Models of infection and exacerbations in COPDAlberto Papi, Marco Contoli, Gaetano Caramori, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 18, 2020
Treatment strategies for asthma: reshaping the concept of asthma managementAlberto Papi, Francesco Blasi, Giorgio Walter Canonica, et al.
Clinical Drug Investigation|February 23, 2012
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthmaSimone Gerzeli, Carla Rognoni, Silvana Quaglini, et al.
Asthma Research and Practice|January 30, 2021
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategyÁlvaro A Cruz, Sara Barile, Elena Nudo, et al.
BMC Pulmonary Medicine|March 19, 2016
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthmaJ Christian Virchow, Roberto Rodriguez-Roisin, Alberto Papi, et al.
Allergy|October 6, 2021
The ICQ asthma algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma managementAlberto Papi, Milos Jesenak, Franco Alfano, et al.
Pageof 43